Skip to main content

Clinical Features and Natural History of Variceal Hemorrhage

Implications for Surveillance and Screening

  • Chapter
Portal Hypertension

Part of the book series: Clinical Gastroenterology ((CG))

  • 1301 Accesses

Abstract

Variceal bleeding is is one of the more frequent and severe complications of cirrhosis. Mortality of a variceal bleeding episode has decreased in the last two decades from 40% to 20% owing to the implementation of effective treatments and i mprovement in general medical care. The management of variccs includes the screening and surveillance of cirrhotic patients to detect varices and its progression, which allows to establish effective prophylactic treatment, the treatment of the acute bleeding episode, and the prevention of variceal rebleeding. These should be based on the knowledge of the natural history and pathophysiology of variceal formation, progression, and rupture, which is the topic covered in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bosch J, D’Amico G, Garcia-Pagan JC. Portal hypertension. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Diseases of the Liver. 9th ed. Lippincott Williams & Wilkins, Philadelphia, 2003, pp. 429–486.

    Google Scholar 

  2. Bosch J, Navasa M, Garcia-Pagan JC, DeLacy AM, Rodes J. Portal hypertension. Med Clin North Am 1989;73:931–953.

    PubMed  CAS  Google Scholar 

  3. Norton TD, Andrews JC, Kamath PS. Management of ectopic varices. Hepatology 1998;28:1154–1158.

    Article  PubMed  CAS  Google Scholar 

  4. D’Amico G, García-Tsao G, Calès P, et al. Diagnosis of portal hypertension. How and when? Portal Hypertension III. Proc Third Baveno Int Consensus Workshop on Definitions, Methodology and Therapeutic Strategies, de Franchis R, ed. Blackwell Science, Oxford, 2001, pp. 36–63.

    Google Scholar 

  5. Viallet A, Marleau D, Huet M, et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology 1975;69:1297–1300.

    PubMed  CAS  Google Scholar 

  6. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419–424.

    Article  PubMed  CAS  Google Scholar 

  7. Rigau J, Bosch J, Bordas JM, et al. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology 1989;96:873–880.

    PubMed  CAS  Google Scholar 

  8. Polio J, Groszmann RJ. Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis 1986;6:318–331.

    PubMed  CAS  Google Scholar 

  9. Bosch J, Groszmann RJ. Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis. Hepatology 1984;4:424–429.

    PubMed  CAS  Google Scholar 

  10. Bosch J, Mastai R, Kravetz D, Bruix J, Rigau J, Rodes J. Measurement of azygos venous blood flow in the evaluation of portal hypertension in patients with cirrhosis. Clinical and haemodynamic correlations in 100 patients. J Hepatol 1985;1:125–139.

    Article  PubMed  CAS  Google Scholar 

  11. Kroeger RJ, Groszmann RJ. Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model. Hepatology 1985;5:97–101.

    Article  PubMed  CAS  Google Scholar 

  12. Chan CC, Lee F Y, Wang SS, et al. Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin. Hepatology 1999;30:630–635.

    Article  PubMed  CAS  Google Scholar 

  13. Mosca P, Lee FY, Kaumann AJ, Groszmann RJ. Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium. Am JPhysiol 1992;263:G544–G550.

    CAS  Google Scholar 

  14. Lee FY, Colombato LA, Albillos A, Groszmann RJ. Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats. Gastroenterology 1993;105:1464–1470.

    PubMed  CAS  Google Scholar 

  15. Sarin SK, Groszmann RJ, Mosca FG, et al. Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension. J Clin Invest 1991;87:1032–1036.

    Article  PubMed  CAS  Google Scholar 

  16. Bellis L, Berzigotti A, Abraldes JG, et al. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis. Hepatology 2003;37:378–384.

    Article  PubMed  CAS  Google Scholar 

  17. Sakurabayashi S, Koh KC, Chen L, Groszmann RJ. Octreotide ameliorates the increase in collateral blood flow during postprandial hyperemia in portal hypertensive rats. J Hepatol 2002;36:507–512.

    Article  PubMed  CAS  Google Scholar 

  18. Luca A, Garcia-Pagan JC, Bosch J, et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997;112:1284–1289.

    Article  PubMed  CAS  Google Scholar 

  19. Garcia-Pagan JC, Feu F, Castells A, et al. Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis. Hepatology 1994;19:595–601.

    Article  PubMed  CAS  Google Scholar 

  20. Garcia-Pagan JC, Santos C, Barbera JA, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology 1996;111:1300–1306.

    Article  PubMed  CAS  Google Scholar 

  21. Luca A, Cirera I, Garcia-Pagan JC, et al. Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis. Gastroenterology 1993;104:222–227.

    PubMed  CAS  Google Scholar 

  22. Escorsell A, Gines A, Llach J, et al. Increasing intra-abdominal pressure increases pressure, volume, and wall tension in esophageal varices. Hepatology 2002;36:936–940.

    PubMed  Google Scholar 

  23. Mahl TC, Groszmann RJ. Pathophysiology of portal hypertension and variceal bleeding. Surg Clin North Am 1990;70:251–266.

    PubMed  CAS  Google Scholar 

  24. Bosch J, Garcia-Pagan JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000;32:141–156.

    Article  PubMed  CAS  Google Scholar 

  25. Casado M, Bosch J, Garcia-Pagan JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998;114:1296–1303.

    Article  PubMed  CAS  Google Scholar 

  26. Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage [see comments]. Gastroenterology 1990;99:1401–1407.

    PubMed  CAS  Google Scholar 

  27. Feu F, Garcia-Pagan JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995;346:1056–1059.

    Article  PubMed  CAS  Google Scholar 

  28. Villanueva C, Minana J, Ortiz J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647–655.

    Article  PubMed  CAS  Google Scholar 

  29. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan J, Rodes J, Bosch J. Hemodynamic response to pharmacologic treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003;37:902–908.

    Article  PubMed  Google Scholar 

  30. Nevens F, Bustami R, Scheys I, Lesaffre E, Fevery J. Variceal pressure is a factor predicting the risk of a first variceal bleeding: a prospective cohort study in cirrhotic patients. Hepatology 1998;27:15–19.

    Article  PubMed  CAS  Google Scholar 

  31. Escorsell A, Bordas JM, Castaneda B, et al. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Hepatology 2000;31:1061–1067.

    Article  PubMed  CAS  Google Scholar 

  32. NIEC. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N Engl J Med 1988;319:983–989.

    Article  Google Scholar 

  33. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332–354.

    Article  PubMed  CAS  Google Scholar 

  34. D’Amico G, Luca A. Natural history. Clinical-hacmodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol 1997;11:243–256.

    Article  PubMed  CAS  Google Scholar 

  35. Christensen E, Fauerholdt L, Schlichting P, Juhl E, Poulsen H, Tygstrup N. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology 1981;81:944–952.

    PubMed  CAS  Google Scholar 

  36. de Franchis R, Primignani M. Natural hi story of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001;5:645–663.

    Article  PubMed  Google Scholar 

  37. Merli M, Nicolini G, Angeloni S, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003;38:266–272.

    Article  PubMed  Google Scholar 

  38. Cales P, Desmorat H, Vinel JP, et al. Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. Gut 1990;31:1298–1302.

    Article  PubMed  CAS  Google Scholar 

  39. Groszmann RJ, Garcia-Tsao G, Makuch R, et al. Multicenter, randomized placebo-controlled trial of non-selective beta-blockers in the prevention of the complications of portal hypertension: final results and identification of a predictive factor. Hepatology 2003;38(Suppl l):206A.

    Article  Google Scholar 

  40. De Franchis R. Evaluation and follow-up of patients with cirrhosis and oesophageal varices. J Hepatol 2003;38:361–363.

    Article  PubMed  Google Scholar 

  41. Pagliaro L, D’Amico G, Pasta L, Politi F, Vizzini G, Traina M. Portal hypertension in cirrhosis. Natural history. In: Bosch J, Groszmann RJ, eds. Portal Hypertension, Pathophysiology and Treatment. Black-well Scientific, Oxford, 1994, pp. 72–92.

    Google Scholar 

  42. Cales P, Oberti F, Payen JL, et al. Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension. Eur J Gastroenterol Hepatol 1999;11:741–745.

    Article  PubMed  CAS  Google Scholar 

  43. Zoli M, Merkel C, Magalotti D, et al. Natural history of cirrhotic patients with small esophageal varices: a prospective study. Am J Gastroenterol 2000;95:503–508.

    Article  PubMed  CAS  Google Scholar 

  44. Merkel C, Marin R, Angeli P, et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 2004;127:476–484.

    Article  PubMed  CAS  Google Scholar 

  45. Vorobioff J, Groszmann RJ, Picabea E, et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 1996;111:701–709.

    Article  PubMed  CAS  Google Scholar 

  46. D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475–505.

    Article  PubMed  CAS  Google Scholar 

  47. Merkel C, Zoli M, Siringo S, et al. Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index. Am J Gastroenterol 2000;95:2915–2920.

    Article  PubMed  CAS  Google Scholar 

  48. D’Amico G, Pagliaro L. The Clinical Course of portal hypertension in liver cirrhosis. In: Rossi P, ed. Diagnostic Imaging and Imaging Guided Therapy. Springer Verlag, Berlin, 2000, pp. 15–24.

    Google Scholar 

  49. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846–852.

    Article  PubMed  Google Scholar 

  50. Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol 1999;94:3292–3296.

    Article  PubMed  CAS  Google Scholar 

  51. Chalasani N, Imperiale TF, Ismail A, et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 1999;94:3285–3291.

    Article  PubMed  CAS  Google Scholar 

  52. Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol 2002;34:81–85.

    Article  PubMed  CAS  Google Scholar 

  53. Giannini E, Botta F, Borro P, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 2003;52:1200–1205.

    Article  PubMed  CAS  Google Scholar 

  54. Saab S, DeRosa V, Nieto J, Durazo F, Han S, Roth B. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. Am J Gastroenterol 2003;98:763–770.

    Article  PubMed  Google Scholar 

  55. Spiegel BM, Targownik L, Dulai GS, Karsan HA, Gralnek IM. Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective? Hepatology 2003;37:366–377.

    Article  PubMed  Google Scholar 

  56. Arguedas MR, Heudebert GR, Eloubeidi MA, Abrams GA, Fallon MB. Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol 2002;97:2441–2452.

    Article  PubMed  Google Scholar 

  57. D’amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003;38:599–612.

    Article  PubMed  Google Scholar 

  58. Merican I, Sprengers D, McCormick PA, Minoli G, Mclntyre N, Burroughs AK. Diurnal pattern of variceal bleeding in cirrhotic patients. J Hepatol 1993;19:15–22.

    Article  PubMed  CAS  Google Scholar 

  59. de Franchis R, Pascal JP, Ancona E, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 1992;15:256–261.

    Article  PubMed  Google Scholar 

  60. de Franchis R. Developing consensus in portal hypertension. J Hepatol 1996;25:390–394.

    Article  PubMed  Google Scholar 

  61. Graham D, Smith J. The course of patients after variceal hemorrhage. Gastroeneterology 1981;80:800–806.

    CAS  Google Scholar 

  62. Bernard B, Cadranel JF, Valla D, Escolano S, Jarlier V, Opolon P. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995;108:1828–1834.

    Article  PubMed  CAS  Google Scholar 

  63. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepalology 1998;27:1207–1212.

    Article  CAS  Google Scholar 

  64. Vivas S, Rodriguez M, Palacio MA, Linares A, Alonso JL, Rodrigo L. Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding. Dig Dis Sci 2001;46:2752–2757.

    Article  PubMed  CAS  Google Scholar 

  65. Ben Ari Z, Cardin F, McCormick AP, Wannamethee G, Burroughs AK. A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol 1999;31:443–450.

    Article  PubMed  CAS  Google Scholar 

  66. Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999;117:626–631.

    Article  PubMed  CAS  Google Scholar 

  67. McCormick PA, O’Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001;49:682–685.

    Article  PubMed  CAS  Google Scholar 

  68. El Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 2000;95:3566–3573.

    Article  PubMed  Google Scholar 

  69. Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003;98:653–659.

    Article  PubMed  Google Scholar 

  70. Nidegger D, Ragot S, Berthelemy P, et al. Cirrhosis and bleeding: the need for very early management. J Hepatol 2003;39:509–514.

    Article  PubMed  Google Scholar 

  71. Gatta A, Merkel C, Amodio P, et al. Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: a multicenter study. Am J Gastroenterol 1994;89:1528–1536.

    PubMed  CAS  Google Scholar 

  72. del Olino JA, Pena A, Serra MA, Wassel AH, Benages A, Rodrigo JM. Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis. J Hepatol 2000;32:19–24.

    Google Scholar 

  73. Cardenas A, Gines P, Uriz J, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 2001;34:671–676.

    Article  PubMed  CAS  Google Scholar 

  74. Garden OJ, Motyl H, Gilmour WH, Utley RJ, Carter DC. Prediction of outcome following acute variceal haemorrhage. Br J Surg 1985;72:91–95.

    Article  PubMed  CAS  Google Scholar 

  75. Ohmann C, Stoltzing H, Wins L, Busch E, Thon K. Prognostic scores in oesophageal or gastric variceal bleeding. Scand J Gastroenterol 1990;25:501–512.

    PubMed  CAS  Google Scholar 

  76. Afessa B, Kubilis PS. Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. Am J Gastroenterol 2000;95:484–489.

    Article  PubMed  CAS  Google Scholar 

  77. Grace ND, Groszmann RJ, Garcia-Tsao G, et al. Portal hypertension and variceal bleeding: an A ASLD single topic symposium. Hepatology 1998;28:868–880.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Abraldes, J.G., Bosch, J. (2005). Clinical Features and Natural History of Variceal Hemorrhage. In: Sanyal, A.J., Shah, V.H. (eds) Portal Hypertension. Clinical Gastroenterology. Humana Press. https://doi.org/10.1007/978-1-59259-885-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-885-4_12

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-386-2

  • Online ISBN: 978-1-59259-885-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics